The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells
July 27th, 2018
17.3K views
Here a simple and well-validated protocol for measuring bulk autophagic sequestration activity in mammalian cells is described. The method is based on quantifying the proportion of lactate dehydrogenase (LDH) in sedimentable cell fractions compared to total cellular LDH levels.
Overview
This article describes a validated protocol for measuring bulk autophagic sequestration activity in mammalian cells. The method quantifies the proportion of lactate dehydrogenase (LDH) in sedimentable cell fractions compared to total cellular LDH levels.
Key Study Components
Area of Science
- Cell Biology
- Autophagy Research
- Cellular Metabolism
Background
- Autophagy is a crucial cellular process for degrading and recycling cellular components.
- Understanding autophagosome formation is essential for elucidating cellular responses to various treatments.
- This method allows for the measurement of endogenous cargo sequestration, providing insights without the need for artificial probes.
- It is applicable across different cell types and conditions.
Purpose of Study
- To provide a reliable protocol for assessing autophagic activity in mammalian cells.
- To explore how different treatments affect bulk autophagy.
- To enhance understanding of the regulation of autophagosome formation.
Methods Used
- Culturing adherent cells in tissue culture flasks.
- Incubating cells in a humidified environment with 5% CO2 at 37 degrees Celsius.
- Allowing cells to grow until a near confluent layer is achieved.
- Quantifying LDH levels in sedimentable fractions versus total cellular levels.
Main Results
- The protocol successfully measures bulk autophagic sequestration activity.
- It demonstrates the impact of various treatments on autophagy.
- Results indicate a reliable method for studying endogenous cargo sequestration.
Conclusions
- This method provides a robust approach to studying autophagy in mammalian cells.
- It is applicable to a wide range of experimental conditions.
- Future studies can leverage this protocol to further investigate autophagic processes.
Frequently Asked Questions
What is the main advantage of this method?
The main advantage is that it measures endogenous cargo sequestration, making it broadly applicable and independent of artificial probes.
What type of cells can be used with this protocol?
The protocol is designed for mammalian cells, specifically adherent cell types.
How does this method contribute to autophagy research?
It provides insights into the regulation of autophagosome formation and the effects of various treatments on bulk autophagy.
What are the incubation conditions for the cells?
Cells should be incubated in a humidified environment with 5% CO2 at 37 degrees Celsius.
Who demonstrates the procedure in the article?
The procedure is demonstrated by Paula Szalai and Morten Luhr, PhD students from the laboratory.
What is the significance of measuring LDH levels?
Measuring LDH levels helps quantify the extent of autophagic sequestration activity in cells.
Executive Industry Relevance
This method enables quantitative measurement of endogenous autophagic sequestration without artificial probes, providing a reliable readout for target validation in autophagy-modulating drug discovery. By reflecting bulk cytosolic cargo capture, it supports mechanistic de-risking of compounds affecting lysosomal degradation pathways. The assay’s applicability across mammalian cell types enhances translational consistency in preclinical screening cascades.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Measures endogenous LDH sequestration to interrogate autophagosome formation regulation independent of overexpression artifacts.
- Operational Value: Uses stable, abundant cytosolic LDH as a native reporter for bulk autophagy flux.
- Scientific Value: Enables pathway clarification via pharmacological and genetic perturbation (e.g., 3MA, SAR-405, ATG knockouts).
Screening & Assay Development
- Scientific Value: Provides quantitative LDH activity readouts in sedimentable versus total fractions for comparative compound screening.
- Operational Value: Employs electrodisruption-based fractionation to isolate autophagosome-associated LDH with high reproducibility.
- Operational Value: Compatible with 12-well plate formats and standard enzymatic LDH detection kits.
Translational & Preclinical Research
- Scientific Value: Demonstrates LC3-independent autophagy dependence on GABARAPs, informing target selection criteria.
- Operational Value: Validated in multiple mammalian cell lines (HEK293, LNCaP, MEFs) supporting cross-model reproducibility.
- Scientific Value: Links sequestration activity to degradation flux when paired with long-lived protein assays.
Pipeline & Workflow Integration
The assay fits within early discovery to evaluate target engagement of autophagy modulators before lead optimization, particularly for lysosomal pathway modulators.
- Discovery Biology: Supports hypothesis testing of autophagosome formation kinetics under nutrient stress or inhibitor treatment.
- Screening: Enables assay-ready quantification of sequestration changes in response to compound libraries.
- Analytics: Generates proportional LDH sedimentation data normalized to untreated controls for statistical comparison.
- Translational Research: Connects to preclinical continuity by confirming genetic dependencies (ATG5, ATG7, ATG9A) in murine models.
- Enterprise Reuse: Establishes a reusable QC checkpoint for autophagy pathway modulation across therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by measuring native cargo sequestration rather than surrogate markers.
- Operational Value: Standardizes autophagy assessment via sedimentation and enzymatic activity readouts.
- Strategic Value: Improves go/no-go decisions by confirming target engagement in degradation pathways.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds based on autophagic flux modulation.
Implementation Considerations
- Requires expertise in cell culture fractionation and enzymatic assay normalization.
- Depends on electroporation equipment and low-speed/high-speed centrifugation capabilities.
- Necessitates standardization of sequestration inhibitor timing (e.g., Bafilomycin A1) across laboratories.
- Adaptation considerations include varying transfection efficiencies in primary versus immortalized cell lines.
- Practical limitation: Assay reflects sequestration only; complementary flux assays needed for degradation confirmation.
Biopharma FAQs
Why does LDH sedimentation measurement matter for target validation?
LDH sedimentation quantifies endogenous cytosolic protein sequestration into autophagosomes, providing a direct measure of bulk autophagy activity. This avoids artifacts from overexpressed reporters and enables accurate assessment of compound effects on autophagosome formation. The method supports target validation by linking treatment to measurable changes in native cargo capture.
How does electrodisruption-based fractionation support discovery pipeline workflows?
Electrodisruption selectively permeabilizes plasma membranes to release cytosolic LDH while preserving organelles, enabling separation of autophagosome-sequestered LDH from free cytosolic pools. This fractionation step ensures that sedimentable LDH reflects autophagic sequestration rather than nonspecific aggregation. The process is compatible with high-throughput sample preparation in multi-well formats.
What do quantitative LDH activity measurements in sedimentable versus total fractions enable?
Quantitative LDH measurements allow calculation of the proportion of total cellular LDH sequestered into autophagosomes, providing a normalized readout of autophagic flux. Subtracting baseline sedimentation in untreated cells from treated samples yields treatment-specific sequestration activity. These measurements support dose-response analysis and statistical comparison across experimental conditions.
Why do replication requirements matter for cross-functional collaboration?
Replication across cell lines and genetic backgrounds (e.g., wild-type versus ATG knockouts) ensures that observed LDH sequestration changes are specific to autophagy regulation rather than cell-line artifacts. Consistent results in HEK293, LNCaP, and MEFs demonstrate assay robustness for shared use between discovery and preclinical teams. Standardized protocols enable reliable data transfer across functional groups in drug discovery projects.
What statistical analysis capabilities are required before implementation?
Implementation requires capability to normalize LDH activity to total protein or cell number and calculate percentage sequestration relative to controls. Statistical comparison of sedimentation proportions across treatment groups (e.g., starved versus inhibited) needs t-tests or ANOVA with post-hoc correction. The assay supports generation of EC50/IC50 values for modulator potency assessment when dose-response curves are generated.
Chapters in this video
0:04
Title
0:40
Cell Seeding and Treatment
2:46
Cell Harvest and Preparation for Electrodisruption
3:53
Plasma Membrane Electrodisruption and Separation of Sedimentable- and Total Cell Fractions
5:50
LDH Extraction and Measurement of LDH Enzymatic Activity
6:55
Results: Monitoring Bulk Autophagic Sequestration Activity in Mammalian Cells
8:43
Conclusion
